7th International Congress on Drug Therapy in HIV Infection

Conference Reports for NATAP


7th International Congress on Drug Therapy in HIV Infection November, 14-18, 2004 Glasgow, UK

	Tenofovir+Abacavir: is there a risk for K65R associated increased failure - (11/19/04) 96-Week Results from '045' Study Comparing Reyataz/r to Kaletra - (11/19/04) Tipranavir Phase III Study Results - (11/19/04) Report From Final Oral Late Breaker Session at Glasgow: Reasons For Stopping HAART in EuroSIDA Cohort - (11/19/04) Kaletra: 6 year followup, study 720 - (11/17/04) Getting Pregnant By Sex with HIV - (11/17/04) Decrease of subcutaneous adipose tissue in HIV patients after replacing established protease inhibitors with atazanavir - (11/17/04) NRTI-Sparing Fuzeon Study & Lipoatrophy - (11/17/04) Day 2 at Glasgow: Tipranavir (RESIST-2); ATV/r v LPV/r 96 wks - (11/17/04) Day 1 Report from Glasgow - (11/17/04)